Sponsored Content
Medicine
Japanese Takeda Lays Foundation Stone for "Laboratory of the Future" in Vienna's Urban Lakeside Aspern
In a symbolic act, the foundation stone was laid for Takeda's "Laboratory of the Future" in Vienna's Seestadt Aspern. With an investment of around 120 million euros, the Japanese pharmaceutical giant represents the company's largest investment to date in Austria in a technically and ecologically optimized new building for biopharmaceutical research and development.
September 22, 2023
First International Cross-Over Transplantation for Kidney Disease at Vienna University Hospital AKH
In the University Hospital Vienna AKH, for the first time made possible by diplomacy, a kidney was implanted in a 31-year-old Viennese, which was flown in from Israel by a living donor. A few hours earlier, a kidney was removed from his brother at Vienna General Hospital and transferred to Israel on the same plane.
January 9, 2023
Payer Takes over Fluid Pack Production from Roche
July 2011 will see Roche Diagnostics in Graz transfer 6 fluid pack production systems to Payer International Technologies in St. Bartholomä. The cooperation with Roche continues.
April 15, 2011
Intercell: Vaccine Development to Suspend
Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710. The share of Intercell crashed seriously.
April 11, 2011
Opportunities for Austrian Medical Technology in the UK
An Austrian study showed Austrian buinesses the opportunities offered by the British market: Austrian exports increased by 15% in 2010.
March 17, 2011
Humanomed to Expand to CEE/SEE
The Austrian Humanomed-Group, a health care company, sees potential to expand to countries in (South) Eastern Europe.
January 28, 2011
F-Star Acquired Major Order
The Vienna-located f-star and Boehringer Ingelheim to collaborate in discovery and development of therapeutic antibodies.
November 23, 2010
Intercell AG: Losses Doubled, Positive Outlook
Today, Vienna-based Intercell AG announced its financial results for the third quarter of 2010 and presented changes to the Management Board.
November 9, 2010